ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough esophageal cancers: experimental drug combos show promise
Disease control CompletedThis study tested several new drug combinations for people with advanced esophageal cancer that had worsened after one prior treatment. Researchers enrolled 90 participants to evaluate whether adding experimental drugs to existing immunotherapy (pembrolizumab) with chemotherapy o…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Study finds new immunotherapy matches standard treatment for esophageal cancer survival
Disease control CompletedThis study looked back at 203 patients with advanced esophageal cancer to compare two different pre-surgery treatment approaches. One group received immunotherapy combined with chemotherapy, while the other received the standard treatment of chemotherapy plus radiation. The resea…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: NA • Sponsor: Yongtao Han • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC